brain disorders – Karma https://karmaimpact.com Advancing people, planet and profit. Thu, 19 Mar 2020 21:07:00 +0000 en-US hourly 1 https://wordpress.org/?v=5.3.2 Musk’s Neuralink Promises Innovation But Requires Trust and Proof /musks-neuralink-promises-innovation-but-requires-trust-and-proof/ /musks-neuralink-promises-innovation-but-requires-trust-and-proof/#respond Wed, 17 Jul 2019 21:35:18 +0000 http://3.222.249.12/?p=10202 While Elon Musk’s brain implant company, Neuralink, has announced plans to begin human patient tests before the end of next year, experts believe proving the technology’s competence may take longer. In an event yesterday, held primarily for recruiting more talent on the Neuralink team, Musk stated that the team is working on a “sewing machine” […]

The post Musk’s Neuralink Promises Innovation But Requires Trust and Proof appeared first on Karma.

]]> /musks-neuralink-promises-innovation-but-requires-trust-and-proof/feed/ 0 Vasopharm to Sell Drug for Traumatic Brain Injury, An Overlooked Killer /vasopharm-to-sell-drug-for-traumatic-brain-injury-an-overlooked-killer/ /vasopharm-to-sell-drug-for-traumatic-brain-injury-an-overlooked-killer/#respond Fri, 12 Jul 2019 20:56:58 +0000 http://3.222.249.12/?p=10122 Germany’s Vasopharm raised $10.7 million as it plans to submit data for a clinical trial next year for its product that seeks to treat an issue with far-reaching social implications: traumatic brain injury.  Led by German PE firm HeidelbergCapital, the funding will help the company prepare for upcoming regulatory reviews of Ronopterin, which is in […]

The post Vasopharm to Sell Drug for Traumatic Brain Injury, An Overlooked Killer appeared first on Karma.

]]> /vasopharm-to-sell-drug-for-traumatic-brain-injury-an-overlooked-killer/feed/ 0 Eisai Tries to Bounce Back With New Dementia Approach /eisai-tries-to-bounce-back-with-new-dementia-approach/ /eisai-tries-to-bounce-back-with-new-dementia-approach/#respond Thu, 11 Jul 2019 20:47:13 +0000 http://3.222.249.12/?p=10097 Eisai Inc. opened an incubator for research into Alzheimer’s and other diseases as part of its new dementia research center, as it seeks to to bounce back from the failure of experimental drug aducanumab. Eisai’s new Genetics Guided Dementia Discovery (G2D2) Center, based in Cambridge, Massachusetts, will look to leverage its experience in genetics, data […]

The post Eisai Tries to Bounce Back With New Dementia Approach appeared first on Karma.

]]> /eisai-tries-to-bounce-back-with-new-dementia-approach/feed/ 0 Biotech Startup Is Vying to Improve Memory Through Brain Implants /biotech-startup-is-vying-to-improve-memory-through-brain-implants/ /biotech-startup-is-vying-to-improve-memory-through-brain-implants/#respond Fri, 28 Jun 2019 21:20:49 +0000 http://3.222.249.12/?p=9702 If Nia Therapeutics succeeds, brain chips will enter medical clinics in three years that will  provide memory generation for all patients suffering from brain injuries or disorders. Michael Kahana, a University of Pennsylvania researcher, and Dan Rizzuto, a neuroscientist, in 2016 founded Nia Therapeutics, where they are trying to develop the memory-restoring surgically-implanted chip. The […]

The post Biotech Startup Is Vying to Improve Memory Through Brain Implants appeared first on Karma.

]]> /biotech-startup-is-vying-to-improve-memory-through-brain-implants/feed/ 0